1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6C0EEFD317B678CB665257DDD003A0D3F
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/C0EEFD317B678CB665257DDD003A0D3F!OpenDocument
18
19OpenDocument
2098.81.24.230
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR
Access. Intelligence. Excellence

| Advanced Search | 0
Research and Consulting Areas of Expertise

Benchmarking Reports Areas of Expertise Report Catalog FAQ
Best Practice Database Areas of Expertise New Research Case Analogs Benefits Types Of Research Current Members
Research and Advisory Services Areas of Expertise Digital Technology Consortium Field Medical Excellence Medical Affairs Consortium White Papers Research Partners Partnership Benefits Contact Us
Excellence Services Pharma and Medical Device Quality New Product Planning Medical Affairs Pharmaceutical Launch Market Research Competitive Intelligence

Industries

Biotechnology Financial Services Healthcare Medical Device Manufacturing Pharmaceuticals Technology and Communications

Functions

Brand Management & Product Leadership Competitive & Business Intelligence Commercial Operations Customer Service Clinical Operations Digital Technologies / AI Human Resources Medical Affairs Market Access Market Research, Analytics & Forecasting

 

Marketing Management Patient Access, Support, Insights and Operations Product Launch Pull Through Pharma Launch Playbook Scenario Planning / War Gaming Sales Supply Chain
Corporate Overview About Benchmarking Benchmarking Books What is a Best Practice? Research Methodology

Our Clients Testimonials

Our Team Careers Best Practices Interns Work at Best Practices, LLC Help Set Research Agenda
Follow Best Practices LLC linkedIn twitter slideshare youtube pinterest

Overview Press Releases Speaking Events Media Coverage Receive Research Updates Contact Us
Address/Email/Phone Schedule a Meeting
Report Catalog Videos
Database Member Home RAS Member Home

» Products & Services » » Market Research, Analytics and Forecasting » Analytics

Report Summary: Big Data in Pharma: Current & Future Trends for Big Data Utilization Across the Health Outcomes Research Function

ID: PSM-317A

Pages: 12

Published: Pre-2019

Delivery Format: Online

 

License Options:


Download FREE Excerpt

 

919-403-0251
Schedule a Meeting

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • STUDY SNAPSHOT
  • KEY FINDINGS
  • VIEW TOC AND LIST OF EXHIBITS

For a complimentary report summary, click "Download FREE Excerpt" on right.

The biopharmaceutical industry has seen an explosion in the availability of big data that can generate valuable insights for key Health Outcomes Research decisions.
However, the biopharmaceutical industry has been slower than other industries in embracing big data analytics due to the inherent costs, difficulty in measuring ROI of Big Data, uneven senior management buy-in and other challenges associated with harnessing large sets of information in varied formats.
As the industry recognizes the huge potential that big data holds for crucial HEOR decisions, rapid steps are being taken to develop greater big data capabilities.
Best Practices, LLC undertook this study to probe current & future trends, winning strategies and best practices for Big Data utilization across the HEOR function. The study investigates the most useful data types and sources for key HEOR decisions; governance policies and leadership and the most impactful data producers, dissemination channels and targets.

Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Chemical; Health Care; Biopharmaceutical; Clinical Research; Laboratories


Companies Profiled:
AstraZeneca; Lundbeck; Esteve; Merck Serono; Bayer; Genentech; Baxter BioScience; GlaxoSmithKline ; Merck; Novartis; Pfizer; Sanofi; Teva Pharmaceutical Industries Ltd

Study Snapshot

Best Practices, LLC engaged 15 leaders from 13 pharmaceutical companies through a benchmarking survey to discuss how their companies approach Big Data utilization within HEOR. Executive interviews were also conducted with function leaders and others from Medical Affairs and Commercial.

Key Findings

Post-Launch and Customer Segmentation Studies Most Common Big Data Projects: Six out of ten benchmark participants used post-launch studies around health outcomes. The second most highly rated reported data type is patient reported outcomes data.

  • Most Have Centralized or Dedicated Big Data Team or Function: Half of the study participants said they have a centralized/dedicated group (Big Data team or function) to support Big Data projects.

Table of Contents

I. Executive Summary pp. 3-8
§ Research Overview pp. 4

§ Universe of Learning pp. 5-6

§ Big Data Team Overview and Key Study Insights pp. 7-8

§ Quantitative Key Findings pp. 9-12

II. Defining Big Data pp. 13-20

III. Data Types and Sources pp. 21-26

IV. Data Producers, Dissemination & Requestors pp. 27-31

V. Centralization pp. 32-34

VI. Governance and Leadership pp. 35-51

VII. About Best Practices, LLC pp. 52


List of Charts & Exhibits

Big Data Use in Medical, HEOR & Commercial Decision-Making

  • Predictive Modeling Use Case
  • Classification Trees and Random Forests
  • Classification Trees in Pharma
  • Predictive Biological Modeling (PBM)
  • Impact of Transactional Data
  • Impact of Reported/Survey Data
  • Impact of Online Data
  • Impact of Scientific/Clinical/Medical Data
  • Impact of Machine-Generated Data
  • Impact of Data Producers
  • Impact of Data Dissemination Channels
  • Impact on Data Dissemination Targets
  • Frequency of Data Requests by Source
  • Do you have a centralized/ dedicated group of individuals to support Big Data projects?
  • Plans for Dedicated Big Data Team
  • Big Data Capabilities and Governance by Region
  • Big Data Use, Leadership by Function
  • Internalization by Capability
  • Please indicate whether you expect your organization to increase its expertise (Big Data capabilities) and whether you expect to increase the capabilities internally (vs. outsourcing) over the next 24 months.
  • Which of the following partners are most impactful/ valuable on Big Data programs and projects?
  • Prevalence of Data Governance Policies
  • Maturity of Capabilities
  • Capabilities of U.S. Companies
  • Capabilities of Global Companies
  • Types of Big Data projects currently used to support medical decisions
  • Types of Big Data projects currently used to support commercial decisions
  • Preference and Popularity of various Study Types

RELATED RESEARCH